Eva E Weinlander, MD
Family Practice · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Weinlander’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$26,433
Medicare paid this office $26,433 for 190 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 94 | $6,466 | $69 |
| Return visit (30+ min) | 68 | $4,452 | $55 |
| Return visit (30+ min) | 50 | $4,408 | $65 |
| Long return visit (40+ min) | 27 | $2,883 | $82 |
| Long return visit (40+ min) | 37 | $2,656 | $59 |
See all 7 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 94 | $6,466 | $69 |
| Return visit (30+ min) | 68 | $4,452 | $55 |
| Return visit (30+ min) | 50 | $4,408 | $65 |
| Long return visit (40+ min) | 27 | $2,883 | $82 |
| Long return visit (40+ min) | 37 | $2,656 | $59 |
| Short return visit (20+ min) | 27 | $2,496 | $54 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $1,100 | $61 |
Who their Medicare patients are
190 Original Medicare patients in 2024. Average age 76 · Women 75% · Also on Medicaid 14% · Health risk score 1.07. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 57% · Diabetes 26% · Coronary heart disease 21% · Chronic kidney disease 19% · Cancer 16% · Depression 16% · Atrial fibrillation 14% · Heart failure 13% · COPD 7% · Stroke 7%.
The office billed $216,914, Medicare allowed $38,179 and paid $26,433; for 427 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 190 | 427 | 76 | 1.07 | $216,914 | $26,433 |
| 2023 | 164 | 375 | 74 | 1.07 | $157,443 | $21,614 |
| 2022 | 148 | 350 | 75 | 1.09 | $164,693 | $21,571 |
| 2021 | 145 | 297 | 75 | 1.15 | $152,729 | $18,579 |
| 2020 | 116 | 240 | 75 | 1.40 | $86,555 | $18,565 |
| 2019 | 123 | 227 | 75 | 1.07 | $55,408 | $19,975 |
| 2018 | 123 | 283 | 73 | 1.07 | $58,933 | $23,303 |
| 2017 | 124 | 279 | 73 | 1.21 | $64,614 | $21,119 |
| 2016 | 134 | 322 | 73 | 1.08 | $88,217 | $24,708 |
| 2015 | 111 | 218 | 74 | 1.18 | $66,871 | $18,634 |
| 2014 | 129 | 290 | 72 | 1.06 | $77,415 | $23,728 |
| 2013 | 120 | 298 | 71 | 1.08 | $81,020 | $23,569 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 84 | $6,908 | $52 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 85 | $5,514 | $65 |
| Short return visit (20+ min) | 31 | $4,610 | $52 |
| Long return visit (40+ min) | 22 | $1,845 | $66 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,166 | $69 |
2022: 5 services
| Return visit (30+ min) | 90 | $8,809 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 71 | $4,342 | $61 |
| Short return visit (20+ min) | 30 | $2,983 | $50 |
| Long return visit (40+ min) | 15 | $1,922 | $87 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,565 | $87 |
2021: 4 services
| Return visit (30+ min) | 75 | $7,135 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 68 | $4,178 | $61 |
| Long return visit (40+ min) | 23 | $2,353 | $81 |
| Short return visit (20+ min) | 23 | $2,105 | $54 |
2020: 5 services
| Return visit (30+ min) | 66 | $5,919 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $3,845 | $142 |
| Long return visit (40+ min) | 24 | $3,005 | $97 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $1,818 | $70 |
| Return visit (30+ min) | 13 | $1,011 | $72 |
2019: 3 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 50 | $7,057 | $141 |
| Long return visit (40+ min) | 37 | $6,045 | $92 |
| Return visit (30+ min) | 64 | $5,973 | $60 |
2018: 4 services
| Long return visit (40+ min) | 51 | $6,880 | $87 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $5,053 | $140 |
| Return visit (30+ min) | 46 | $2,955 | $57 |
| Return visit (30+ min) | 30 | $2,472 | $71 |
2017: 3 services
| Return visit (30+ min) | 67 | $6,818 | $60 |
| Long return visit (40+ min) | 42 | $5,380 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $4,987 | $139 |
2016: 4 services
| Long return visit (40+ min) | 38 | $7,134 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 46 | $6,332 | $138 |
| Return visit (30+ min) | 68 | $6,139 | $57 |
| Short return visit (20+ min) | 21 | $3,099 | $42 |
2015: 4 services
| Return visit (30+ min) | 54 | $5,019 | $64 |
| Long return visit (40+ min) | 37 | $5,008 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $4,976 | $138 |
| Short return visit (20+ min) | 14 | $1,219 | $44 |
2014: 4 services
| Long return visit (40+ min) | 45 | $9,021 | $93 |
| Return visit (30+ min) | 81 | $8,027 | $63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,235 | $135 |
| Short return visit (20+ min) | 12 | $819 | $37 |
2013: 3 services
| Return visit (30+ min) | 80 | $9,177 | $62 |
| Long return visit (40+ min) | 51 | $9,009 | $82 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 16 | $2,982 | $186 |
Drugs they prescribed that Part D paid
$74,896
Pharmacies billed $74,896 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,040 generic and fewer than 11 brand-name prescriptions · $74,896 in drug cost · 19 antibiotic prescriptions to 14 people · 12 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 44 | $36,834 | $837 |
| Premarin | 11 | $4,978 | $453 |
| Synthroid | 25 | $2,413 | $97 |
| Estradiol | 14 | $1,690 | $121 |
| Atorvastatin | 109 | $895 | $8 |
See all 29 drugs
| Ozempic | 44 | $36,834 | $837 |
| Premarin | 11 | $4,978 | $453 |
| Synthroid | 25 | $2,413 | $97 |
| Estradiol | 14 | $1,690 | $121 |
| Atorvastatin | 109 | $895 | $8 |
| Gabapentin | 33 | $762 | $23 |
| Levothyroxine | 49 | $615 | $13 |
| Lisinopril | 60 | $595 | $10 |
| Losartan | 63 | $502 | $8 |
| Amlodipine Besylate | 54 | $435 | $8 |
| Fluticasone Propionate | 14 | $432 | $31 |
| Bupropion Xl | 11 | $373 | $34 |
| Rosuvastatin | 32 | $356 | $11 |
| Mirtazapine | 12 | $346 | $29 |
| Chlorthalidone | 11 | $284 | $26 |
| Metoprolol | 17 | $275 | $16 |
| Fluoxetine | 16 | $273 | $17 |
| Escitalopram | 17 | $269 | $16 |
| Hydrochlorothiazide | 28 | $240 | $9 |
| Pantoprazole | 12 | $201 | $17 |
| Omeprazole | 26 | $189 | $7 |
| Sertraline | 15 | $186 | $12 |
| Tamsulosin | 14 | $164 | $12 |
| Metformin | 28 | $152 | $5 |
| Montelukast | 13 | $143 | $11 |
| Simvastatin | 14 | $135 | $10 |
| Alendronate | 34 | $67 | $2 |
| Zolpidem | 14 | $57 | $4 |
| Paxlovid | 11 | $0 | $0 |
Year by year
| 2024 | 1,190 | 147 | None | None | $74,896 |
| 2023 | 1,241 | 156 | 1% (14) | 12% | $86,207 |
| 2022 | 1,105 | 144 | 2% (17) | None | $75,359 |
| 2021 | 948 | 145 | 2% (14) | None | $47,106 |
| 2020 | 1,028 | 135 | 3% (34) | None | $60,134 |
| 2019 | 968 | 120 | 4% (34) | 16% | $57,324 |
| 2018 | 1,064 | 126 | 4% (38) | 19% | $74,593 |
| 2017 | 1,049 | 111 | 5% (54) | 18% | $66,791 |
| 2016 | 953 | 108 | 4% (33) | 19% | $65,080 |
| 2015 | 1,007 | 114 | 2% (21) | 23% | $69,462 |
| 2014 | 1,016 | 103 | 1% (11) | 27% | $84,400 |
| 2013 | 1,035 | 104 | 3% (33) | None | $72,627 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 30 drugs
| Premarin | 19 | $7,516 | $396 |
| Synthroid | 21 | $2,026 | $96 |
| Atorvastatin | 114 | $1,737 | $15 |
| Levothyroxine | 74 | $1,367 | $18 |
| Gabapentin | 40 | $1,293 | $32 |
| Amlodipine Besylate | 52 | $1,070 | $21 |
| Losartan | 51 | $828 | $16 |
| Enalapril Maleate | 14 | $762 | $54 |
| Potassium Chloride | 13 | $751 | $58 |
| Mirtazapine | 16 | $645 | $40 |
| Tamsulosin | 26 | $573 | $22 |
| Metoprolol | 22 | $551 | $25 |
| Bupropion Hcl Sr | 13 | $526 | $40 |
| Chlorthalidone | 16 | $491 | $31 |
| Lisinopril | 62 | $481 | $8 |
| Bupropion Xl | 12 | $406 | $34 |
| Fluoxetine | 11 | $380 | $35 |
| Pantoprazole | 11 | $374 | $34 |
| Rosuvastatin | 22 | $284 | $13 |
| Metformin | 22 | $274 | $12 |
| Simvastatin | 24 | $269 | $11 |
| Triamterene-Hydrochlorothiazid | 13 | $267 | $21 |
| Omeprazole | 25 | $228 | $9 |
| Escitalopram | 15 | $220 | $15 |
| Azelastine | 11 | $197 | $18 |
| Alendronate | 24 | $181 | $8 |
| Sertraline | 17 | $153 | $9 |
| Hydrochlorothiazide | 29 | $146 | $5 |
| Paxlovid (Eua) | 11 | $117 | $11 |
| Zolpidem | 23 | $109 | $5 |
2022: 29 drugs
| Eliquis | 12 | $13,950 | $1,162 |
| Premarin | 28 | $7,342 | $262 |
| Levothyroxine | 82 | $1,755 | $21 |
| Atorvastatin | 105 | $1,447 | $14 |
| Synthroid | 11 | $1,265 | $115 |
| Mirtazapine | 15 | $978 | $65 |
| Amlodipine Besylate | 64 | $827 | $13 |
| Albuterol Sulfate Hfa | 20 | $800 | $40 |
| Chlorthalidone | 16 | $769 | $48 |
| Potassium Chloride | 13 | $764 | $59 |
| Escitalopram | 14 | $668 | $48 |
| Lisinopril | 53 | $661 | $12 |
| Losartan | 45 | $626 | $14 |
| Gabapentin | 26 | $504 | $19 |
| Duloxetine | 15 | $482 | $32 |
| Bupropion Hcl Sr | 13 | $369 | $28 |
| Omeprazole | 19 | $362 | $19 |
| Simvastatin | 28 | $322 | $11 |
| Pantoprazole | 12 | $293 | $24 |
| Triamterene-Hydrochlorothiazid | 15 | $262 | $17 |
| Allopurinol | 14 | $244 | $17 |
| Montelukast | 13 | $243 | $19 |
| Zolpidem | 27 | $214 | $8 |
| Sertraline | 12 | $200 | $17 |
| Trazodone | 18 | $166 | $9 |
| Alendronate | 21 | $153 | $7 |
| Hydrocodone-Acetaminophen | 11 | $150 | $14 |
| Metformin | 14 | $128 | $9 |
| Hydrochlorothiazide | 14 | $61 | $4 |
2021: 26 drugs
| Premarin | 11 | $3,549 | $323 |
| Levothyroxine | 77 | $1,937 | $25 |
| Albuterol Sulfate Hfa | 23 | $1,552 | $67 |
| Atorvastatin | 85 | $1,518 | $18 |
| Duloxetine | 13 | $819 | $63 |
| Lisinopril | 47 | $738 | $16 |
| Losartan | 37 | $561 | $15 |
| Escitalopram | 15 | $549 | $37 |
| Chlorthalidone | 13 | $525 | $40 |
| Amlodipine Besylate | 52 | $504 | $10 |
| Fluticasone Propionate | 15 | $440 | $29 |
| Gabapentin | 30 | $439 | $15 |
| Omeprazole | 16 | $348 | $22 |
| Simvastatin | 25 | $301 | $12 |
| Diclofenac | 15 | $295 | $20 |
| Montelukast | 19 | $280 | $15 |
| Tamsulosin | 12 | $264 | $22 |
| Pantoprazole | 12 | $189 | $16 |
| Acyclovir | 11 | $181 | $16 |
| Triamterene-Hydrochlorothiazid | 15 | $180 | $12 |
| Hydrocodone-Acetaminophen | 11 | $173 | $16 |
| Allopurinol | 11 | $173 | $16 |
| Zolpidem | 24 | $151 | $6 |
| Alendronate | 11 | $134 | $12 |
| Metformin | 15 | $124 | $8 |
| Trazodone | 18 | $108 | $6 |
2020: 30 drugs
| Eliquis | 24 | $8,061 | $336 |
| Zolpidem | 16 | $2,148 | $134 |
| Levothyroxine | 67 | $1,995 | $30 |
| Premarin | 11 | $1,810 | $165 |
| Atorvastatin | 93 | $1,683 | $18 |
| Albuterol Sulfate Hfa | 14 | $1,503 | $107 |
| Synthroid | 14 | $1,112 | $79 |
| Losartan | 38 | $703 | $19 |
| Duloxetine | 16 | $625 | $39 |
| Chlorthalidone | 11 | $608 | $55 |
| Lisinopril | 33 | $565 | $17 |
| Escitalopram | 13 | $558 | $43 |
| Tamsulosin | 16 | $491 | $31 |
| Gabapentin | 37 | $445 | $12 |
| Triamterene-Hydrochlorothiazid | 23 | $413 | $18 |
| Diclofenac | 19 | $369 | $19 |
| Fluticasone Propionate | 22 | $360 | $16 |
| Sumatriptan | 13 | $352 | $27 |
| Donepezil | 14 | $343 | $24 |
| Omeprazole | 16 | $339 | $21 |
| Simvastatin | 25 | $289 | $12 |
| Alendronate | 20 | $288 | $14 |
| Hydrocodone-Acetaminophen | 19 | $272 | $14 |
| Amlodipine Besylate | 49 | $266 | $5 |
| Carvedilol | 11 | $202 | $18 |
| Metformin | 23 | $123 | $5 |
| Metformin Hcl Er | 11 | $120 | $11 |
| Pantoprazole | 12 | $96 | $8 |
| Hydrochlorothiazide | 12 | $49 | $4 |
| Trazodone | 14 | $47 | $3 |
2019: 23 drugs
| Eliquis | 23 | $5,720 | $249 |
| Zolpidem | 21 | $2,447 | $117 |
| Potassium Chloride | 21 | $2,154 | $103 |
| Levothyroxine | 68 | $1,694 | $25 |
| Synthroid | 15 | $1,647 | $110 |
| Atorvastatin | 77 | $1,384 | $18 |
| Gabapentin | 41 | $688 | $17 |
| Losartan | 34 | $447 | $13 |
| Amlodipine Besylate | 47 | $440 | $9 |
| Tamsulosin | 18 | $417 | $23 |
| Bupropion Hcl Sr | 15 | $404 | $27 |
| Lisinopril | 33 | $353 | $11 |
| Fluticasone Propionate | 17 | $338 | $20 |
| Triamterene-Hydrochlorothiazid | 25 | $309 | $12 |
| Omeprazole | 18 | $288 | $16 |
| Carvedilol | 11 | $277 | $25 |
| Simvastatin | 23 | $208 | $9 |
| Hydrocodone-Acetaminophen | 13 | $191 | $15 |
| Metformin | 23 | $184 | $8 |
| Fluoxetine | 11 | $165 | $15 |
| Alendronate | 14 | $137 | $10 |
| Clonazepam | 11 | $64 | $6 |
| Hydrochlorothiazide | 15 | $60 | $4 |
2018: 28 drugs
| Eliquis | 16 | $7,339 | $459 |
| Advair Diskus | 12 | $3,862 | $322 |
| Levothyroxine | 100 | $2,197 | $22 |
| Atorvastatin | 77 | $1,596 | $21 |
| Synthroid | 16 | $1,557 | $97 |
| Zolpidem | 20 | $1,546 | $77 |
| Proair Hfa | 18 | $1,249 | $69 |
| Potassium Chloride | 15 | $1,040 | $69 |
| Losartan | 49 | $626 | $13 |
| Fluticasone Propionate | 23 | $524 | $23 |
| Triamterene-Hydrochlorothiazid | 34 | $520 | $15 |
| Gabapentin | 34 | $500 | $15 |
| Amlodipine Besylate | 48 | $455 | $9 |
| Metoprolol | 14 | $413 | $30 |
| Simvastatin | 30 | $291 | $10 |
| Liothyronine | 11 | $291 | $26 |
| Carvedilol | 13 | $278 | $21 |
| Bupropion Hcl Sr | 17 | $272 | $16 |
| Donepezil | 12 | $265 | $22 |
| Fluoxetine | 11 | $185 | $17 |
| Alendronate | 15 | $166 | $11 |
| Lisinopril | 23 | $135 | $6 |
| Metformin | 22 | $111 | $5 |
| Pravastatin | 14 | $104 | $7 |
| Amitriptyline | 11 | $100 | $9 |
| Hydrocodone-Acetaminophen | 13 | $99 | $8 |
| Citalopram Hbr | 15 | $98 | $7 |
| Hydrochlorothiazide | 16 | $53 | $3 |
2017: 26 drugs
| Levothyroxine | 71 | $1,612 | $23 |
| Synthroid | 21 | $1,488 | $71 |
| Atorvastatin | 64 | $1,174 | $18 |
| Duloxetine | 14 | $781 | $56 |
| Oxycodone-Acetaminophen | 11 | $637 | $58 |
| Losartan | 69 | $595 | $9 |
| Triamterene-Hydrochlorothiazid | 44 | $459 | $10 |
| Metoprolol | 17 | $447 | $26 |
| Omeprazole | 24 | $435 | $18 |
| Amlodipine Besylate | 46 | $422 | $9 |
| Zolpidem | 26 | $411 | $16 |
| Potassium Chloride | 15 | $373 | $25 |
| Nifedipine Er | 14 | $303 | $22 |
| Gabapentin | 19 | $265 | $14 |
| Enalapril Maleate | 15 | $251 | $17 |
| Simvastatin | 31 | $241 | $8 |
| Lisinopril | 29 | $209 | $7 |
| Methadone | 12 | $196 | $16 |
| Hydrocodone-Acetaminophen | 15 | $192 | $13 |
| Furosemide | 11 | $178 | $16 |
| Bupropion Hcl Sr | 15 | $153 | $10 |
| Clopidogrel | 15 | $115 | $8 |
| Nortriptyline | 11 | $109 | $10 |
| Pravastatin | 14 | $88 | $6 |
| Citalopram Hbr | 11 | $78 | $7 |
| Metformin | 23 | $59 | $3 |
2016: 25 drugs
| Estradiol | 16 | $1,448 | $90 |
| Duloxetine | 15 | $1,409 | $94 |
| Atorvastatin | 86 | $1,294 | $15 |
| Metoprolol | 26 | $1,025 | $39 |
| Levothyroxine | 40 | $1,024 | $26 |
| Hydrocodone-Acetaminophen | 16 | $871 | $54 |
| Gabapentin | 18 | $690 | $38 |
| Potassium Chloride | 20 | $653 | $33 |
| Enalapril Maleate | 19 | $627 | $33 |
| Bupropion Hcl Sr | 17 | $414 | $24 |
| Losartan | 53 | $375 | $7 |
| Triamterene-Hydrochlorothiazid | 37 | $371 | $10 |
| Tamsulosin | 14 | $337 | $24 |
| Furosemide | 25 | $334 | $13 |
| Zolpidem | 21 | $333 | $16 |
| Simvastatin | 30 | $296 | $10 |
| Lisinopril | 39 | $274 | $7 |
| Pantoprazole | 16 | $249 | $16 |
| Lorazepam | 13 | $208 | $16 |
| Omeprazole | 24 | $188 | $8 |
| Amlodipine Besylate | 32 | $168 | $5 |
| Fluoxetine | 16 | $146 | $9 |
| Metformin | 14 | $82 | $6 |
| Spironolactone | 11 | $76 | $7 |
| Pravastatin | 13 | $59 | $5 |
2015: 21 drugs
| Potassium Chloride | 25 | $1,499 | $60 |
| Atorvastatin | 98 | $1,451 | $15 |
| Metoprolol | 31 | $1,256 | $41 |
| Levothyroxine | 37 | $1,098 | $30 |
| Duloxetine | 12 | $1,004 | $84 |
| Enalapril Maleate | 24 | $823 | $34 |
| Omeprazole | 42 | $483 | $11 |
| Zolpidem | 24 | $383 | $16 |
| Fluticasone Propionate | 31 | $344 | $11 |
| Losartan | 47 | $320 | $7 |
| Bupropion Hcl Sr | 13 | $317 | $24 |
| Pantoprazole | 18 | $296 | $16 |
| Triamterene-Hydrochlorothiazid | 34 | $285 | $8 |
| Amlodipine Besylate | 42 | $210 | $5 |
| Irbesartan | 12 | $208 | $17 |
| Simvastatin | 35 | $206 | $6 |
| Prednisone | 11 | $148 | $13 |
| Metformin | 18 | $119 | $7 |
| Citalopram Hbr | 23 | $112 | $5 |
| Hydrochlorothiazide | 12 | $66 | $6 |
| Fluoxetine | 19 | $48 | $3 |
2014: 27 drugs
| Nuvigil | 12 | $6,247 | $521 |
| Namenda | 13 | $4,200 | $323 |
| Spiriva | 12 | $3,733 | $311 |
| Flovent Hfa | 11 | $3,121 | $284 |
| Atorvastatin | 79 | $1,349 | $17 |
| Metoprolol | 30 | $1,275 | $43 |
| Omeprazole | 44 | $752 | $17 |
| Levothyroxine | 27 | $735 | $27 |
| Amlodipine Besylate | 65 | $681 | $10 |
| Montelukast | 16 | $589 | $37 |
| Enalapril Maleate | 15 | $477 | $32 |
| Synthroid | 12 | $464 | $39 |
| Fluticasone Propionate | 34 | $443 | $13 |
| Zolpidem | 58 | $390 | $7 |
| Nifedical Xl | 11 | $362 | $33 |
| Triamterene-Hydrochlorothiazid | 34 | $335 | $10 |
| Metformin | 24 | $264 | $11 |
| Alendronate | 19 | $254 | $13 |
| Donepezil | 13 | $221 | $17 |
| Furosemide | 14 | $210 | $15 |
| Losartan | 30 | $182 | $6 |
| Pantoprazole | 13 | $164 | $13 |
| Simvastatin | 12 | $138 | $12 |
| Citalopram Hbr | 26 | $136 | $5 |
| Prednisone | 12 | $117 | $10 |
| Atenolol | 13 | $110 | $8 |
| Hydrochlorothiazide | 13 | $64 | $5 |
2013: 29 drugs
| Nuvigil | 13 | $6,004 | $462 |
| Advair Diskus | 14 | $5,963 | $426 |
| Spiriva | 11 | $3,193 | $290 |
| Atorvastatin | 56 | $1,525 | $27 |
| Montelukast | 22 | $1,136 | $52 |
| Omeprazole | 54 | $1,030 | $19 |
| Vivelle-Dot | 13 | $985 | $76 |
| Metoprolol | 22 | $816 | $37 |
| Proair Hfa | 17 | $768 | $45 |
| Potassium Chloride | 15 | $752 | $50 |
| Gabapentin | 14 | $695 | $50 |
| Amlodipine Besylate | 55 | $667 | $12 |
| Oxycodone Hcl-Acetaminophen | 11 | $640 | $58 |
| Synthroid | 12 | $524 | $44 |
| Enalapril Maleate | 35 | $458 | $13 |
| Nifedical Xl | 13 | $434 | $33 |
| Triamterene-Hctz | 37 | $407 | $11 |
| Levothyroxine | 27 | $387 | $14 |
| Fluticasone Propionate | 15 | $331 | $22 |
| Chlorthalidone | 12 | $329 | $27 |
| Donepezil | 13 | $315 | $24 |
| Alendronate | 13 | $313 | $24 |
| Zolpidem | 55 | $311 | $6 |
| Losartan | 24 | $296 | $12 |
| Lisinopril | 20 | $162 | $8 |
| Prednisone | 11 | $124 | $11 |
| Atenolol | 17 | $124 | $7 |
| Citalopram Hbr | 20 | $117 | $6 |
| Hydrochlorothiazide | 15 | $69 | $5 |
Professional record
- NPI
- 1164564217
- Licence
- CA A049121
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 300 Pasteur Dr # N329, Palo Alto, CA, 94305
- NPI first listed
- 2007-02-13
- NPI last updated
- 2024-04-12
- NPI record certified
- 2024-04-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr # N329, Palo Alto, CA, 94305